Ivarmacitinib Efficacious for Moderate-to-Severe Atopic Dermatitis

More patients achieved IGA score of 0 or 1 with at least a 2-grade improvement with once-daily 4-mg or 8-mg ivarmacitinib versus placebo
eczema atopic dermatitis rash
Adobe Stock
Medically Reviewed By:
Meeta Shah, M.D.
Published on: 
Updated on: 
Loading content, please wait...

Related Stories

No stories found.
logo
www.healthday.com